Monday, November 10, 2008

7:30 – 8:30 a.m.
Breakfast & Registration

8:30 – 8:45 a.m.
Welcome & Introduction
- Caroline A. Kovac, PhD, Managing Director, Burrill & Company

8:45 – 10:00 a.m.
Industry Update:
State of the Personalized, Predictive and Preventative Medicine World
- G. Steven Burrill, CEO, Burrill & Company

10:00 – 10:30 a.m.
Break

10:30 – 11:45 a.m.
Personalized Medicine in the Clinic: Advances in Diagnosis and Treatment of Cancer
Panelists:
- Franklyn G. Prendergast, MD, PhD, Director, Center for Individualized Medicine Research, Mayo Clinic
- Randy Scott, PhD, Chairman & CEO, Genomic Health
- Jeff Trent, PhD, President & Scientific Director, Translational Genomics Research Institute (TGen)
- William D. Young, Chairman & CEO, Monogram Biosciences
Moderator: Caroline A. Kovac, PhD, Managing Director, Burrill & Company

11:45 a.m. – 1:15 p.m.
‘Conversations with Experts’ Luncheon
Informal discussions on business, economic, political and therapeutic topics with an international group of personalized medicine leaders from corporate, academic and government sectors.
Expert Hosts:
- Mari Baker, President & CEO, Navigenics
- Asif Dhar, MD, Senior Manager, Deloitte Consulting
- Eugenia Garret-Wackowski, Partner, Townsend and Townsend and Crew LLP
- Sami N. Guzder, Chief Scientist, Avesthagen
- Matthew Hudes, National Managing Principal, Deloitte Consulting
- Robert J. Monroe, MD, PhD, CMO, BioImagene
- Franklyn G. Prendergast, MD, PhD, Director, Center for Individualized Medicine Research, Mayo Clinic
- Randy Scott, PhD, Chairman & CEO, Genomic Health
- John J. Sninsky, PhD, VP, Discovery Research, Celera
- Eric J. Topol, MD, Director, Scripps Translational Science Institute; Dean, Scripps School of Medicine; Chief Academic Officer, Scripps Health
- William Wachsman, MD, PhD, Associate Professor, Medicine, UCSD

1:15 – 2:15 p.m.
Interview: The FDA and Regulatory Approval
- Alberto Gutierrez, PhD, Deputy Director, New Product Evaluation, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD), Center for Devices and Radiological Health (CDRH), FDA
Interviewed by: Ann F. Hanham, PhD, Managing Director, Burrill & Company

2:15 – 2:30 p.m.
Break

2:30 – 3:15 p.m.
Keynote Speaker: Personalized Medicine After Herceptin
- Susan Desmond-Hellmann, MD, MPH, President, Product Development, Genentech
Introduced by: William D. Young, Chairman & CEO, Monogram Biosciences

3:15 – 4:30 p.m.
Personalized Medicine in the Clinic: Beyond Cancer
Panelists:
- Dean Sproles, CEO, Iverson Genetics Diagnostics
- Timothy Thompson, President & CEO, Proventys
- Eric J. Topol, MD, Director, Scripps Translational Science Institute; Dean, Scripps School of Medicine; Chief Academic Officer, Scripps Health
Moderator: Garrett Vygantas, MD, Senior Associate, Burrill & Company

4:30 – 5:00 p.m.
Presentation: Personalized Medicine - The Challenges Ahead
- Paul H. Keckley, PhD, Executive Director, Deloitte Center for Health Solutions

5:00 p.m.
Day One Meeting Wrap-Up
- Caroline A. Kovac, PhD, Managing Director, Burrill & Company

5:00 – 6:30 p.m.
Networking Reception



Tuesday, November 11, 2008

7:30 – 8:30 a.m.
Breakfast

8:30 – 10:00 a.m.
Personalized Medicine and Public Policy
Panelists:
- M. Kathleen Behrens, PhD, Member, President’s Council of Advisors on Science and Technology
- Kathryn Lowell, Deputy Secretary, Health Systems and Life Sciences Business, Transportation and Housing Agency
- Robert Wells, Partner, HealthFutures, LLC
Moderator: Caroline A. Kovac, PhD, Managing Director, Burrill & Company

10:00– 10:30 a.m.
Break

10:30 a.m. – 12:00 p.m.
Patient-Centric Medicine: PM from the Patient’s Point of View
Panelists:
- Mari Baker, President & CEO, Navigenics
- Michael F. Christman, PhD, President & CEO, Coriell Institute for Medical Research
- Steven A. R. Murphy, MD, President, Helix Health & The Gene Sherpa
Moderator: Caroline A. Kovac, PhD, Managing Director, Burrill & Company

12:00 – 1:00 p.m.
Lunch

1:00 – 2:30 p.m.
Changing Business Models in Personalized Medicine
Panelists:
- Matt Hudes, National Managing Principal, Deloitte Consulting
- Michael Paul, PhD, President & CEO, LineaGen
- Bruce Quinn, MD, PhD, Senior Health Policy Specialist, Foley Hoag; Former California Medical Director, NHIC
- William J. Welch, SVP & Chief Commercial Officer, Monogram Biosciences
Moderator: Mohan S. Iyer, Managing Director, Burrill & Company

2:30 – 2:45 p.m.
Meeting Wrap-Up
- Caroline A. Kovac, PhD, Managing Director, Burrill & Company